The immunogenicity of influenza virus vaccine in solid organ transplant recipients

Clinical Infectious Diseases

Volumn 22, Issue 2, 1996, Pages 295-302

  Blumberg, Emily A ^b   Albano, Caroline ^b   Pruett, Timothy ^b   Isaacs, Ross ^b   Fitzpatrick, Jane ^b   Bergin, James ^b   Crump, Carolyn ^b   Hayden, Frederick G ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGENICITY; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

EID: 0030058533     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.2.295     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: part I, vaccines. MMWR Morb Mortal Wkly Rep 1994;43(RR-9):1-13.
2. Ljungman P, Andersson J, Aschan J, et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993;17:244-7.
3. Aschan J, Ringdén O, Ljungman P, Andersson J, Lewensohn-Fuchs I, Forsgren M. Influenza B in transplant patients. Scand J Infect Dis 1989;21:349-50.
4. Mauch TJ, Bratton S, Myers T, Krane E, Gentry SR, Kashtan CE. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatr 1994;94:225-9.
5. Briggs JD, Timbury MC, Paton AM, Bell PR. Viral infection and renal transplant rejection. Br Med J 1972;4:520-2.
6. Keane WR, Helderman JH, Luby J, Gailiunas P, Hull AR, Kokko JP. Epidemic renal transplant rejection associated with influenza A Victoria [abstract]. Kidney Int 1978;14:793.
7. Douglas RG. Prophylaxis and treatment of influenza. N Engl J Med 1990;322:443-50.
8. Kobashigawa JA, Warner-Stevenson L, Johnson BL, et al. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant Proc 1993;25:2738-9.
9. Grekas D, Alivanis P, Kiriazopoulou V, et al. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 1993;31:553-6.
10. Carroll RN, Marsh SD, O'Donoghue EP, Breeze DC, Shackman R. Response to influenza vaccine by renal transplant patients. Br Med J 1974;2:701-3.
11. Pabico RC, Douglas RG, Betts RF, McKenna BA, Freeman RB. Antibody response to influenza vaccination in renal transplant patients. Ann Intern Med 1976;85:431-6.
12. Kumar SS, Ventura AK, VanderWerf B. Influenza vaccination in renal transplant recipients. JAMA 1978;239:840-2.
13. Rytel MW, Niebojewski RA, Rosenkranz MA, Sedmak G. Humoral and cell mediated immune response to bivalent influenza A/NJ/76 and A/ Vict/75 vaccine in renal allograft recipients. Dev Biol Stand 1977;39:225-30.
14. Stiver HG, Graves P, Meiklejohn G, Schroter G, Eickhoff TC. Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun 1977;16:738-41.
15. Versluis DJ, Beyer WEP, Masurel N, Wenting GJ, Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplant 1986; 42:376-9.
16. Huang K-L, Armstrong JA, Ho M. Antibody response after influenza immunization in renal transplant patients receiving cyclosporine A or azathioprine. Infect Immun 1983;40:421-4.
17. Palmer DF, Coleman MT, Dowle WR, Schild GC. Advanced laboratory techniques for influenza diagnosis: procedural guide. Atlanta: Centers for Disease Control, 1976;85:431.
18. Kilbourne ED, Butler WT, Rossen RD. Specific immunity in influenza - summary of influenza workshop III. J Infect Dis 1973;127:220-36.
19. Briggs WA, Rozek RJ, Migdal SD, et al. Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 1980;92:471-7.
20. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis 1993;12:778-82.
21. Cicogna C, White M. Influenza immunization for cancer patients. Infections in Medicine 1993;10:12, 17.
22. Engelhard D, Nagler A, Hardan I, et al. Antibody response to a two-dose regimen of influenza vaccine in allogenic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993;11: 1-5.
23. Brandriss MW, Betts RF, Mathur U, Douglas RG Jr. Response of elderly subjects to monovalent A/USSR/77 (H1N1) and trivalent A/USSR/ 77 (H1N1)-A/Texas/77 (H3N2)-B/Hong Kong/72 vaccines. Am Rev Respir Dis 1981;124:681-4.
24. Zei T, Neri M, Iorio AM. Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age. Vaccine 1991;9:613-7.
25. Dolin R, Reichman RC, Madore HP, et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982;307:580-4.